drugset / Trial / NCT05643729

Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)

NCT05643729 ↗

Phase 1/2 Suspended 20 enrolled ZEO ScientifiX, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of Zofin for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).

Timeline

Start
2023-11-15
Primary completion
2024-05-30
Completion
2024-08-31

Outcome

Outcome not reported

Stopped: “Study is on hold”

Drugs

EvaluationDrugModalityDoseRoute
Subject Zofin Other / unclassified 1 ml Intravenous